News
Media
Conferences
Publications
CME/CE
Resources
Subscribe
Partners

Frahad Ravandi-Kashani, MD

Articles by Frahad Ravandi-Kashani, MD

Measurable Residual Disease's Role in the Relapse Setting

ByFrahad Ravandi-Kashani, MD

October 29th 2019

MRD can prove useful in the treatment of patients with hairy cell leukemia who relapsed.

Latest Updated Articles

Measurable Residual Disease's Role in the Relapse Setting
Published: October 29th 2019 | Updated:

Trending on Oncology Nursing News

Monitoring Later Cytopenias With CAR T-Cell Therapy

© 2025 MJH Life Sciences^®

All rights reserved.